Marshall Wace North America L.P. purchased a new stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 26,948 shares of the medical equipment provider’s stock, valued at approximately $943,000.

Several other hedge funds have also modified their holdings of SNN. Bank of Montreal Can grew its holdings in shares of Smith & Nephew SNATS by 1.3% during the first quarter. Bank of Montreal Can now owns 23,315 shares of the medical equipment provider’s stock valued at $721,000 after buying an additional 289 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in shares of Smith & Nephew SNATS during the first quarter valued at $2,884,000. Wells Fargo & Company MN grew its holdings in shares of Smith & Nephew SNATS by 21.4% during the first quarter. Wells Fargo & Company MN now owns 429,522 shares of the medical equipment provider’s stock valued at $13,285,000 after buying an additional 75,572 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Smith & Nephew SNATS by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 66,199 shares of the medical equipment provider’s stock valued at $2,048,000 after buying an additional 2,509 shares in the last quarter. Finally, Comerica Bank grew its holdings in shares of Smith & Nephew SNATS by 1.8% during the first quarter. Comerica Bank now owns 32,120 shares of the medical equipment provider’s stock valued at $1,064,000 after buying an additional 578 shares in the last quarter. Institutional investors and hedge funds own 6.36% of the company’s stock.

Smith & Nephew SNATS, Inc. (SNN) opened at 37.07 on Friday. The firm has a 50-day moving average price of $35.57 and a 200-day moving average price of $33.73. Smith & Nephew SNATS, Inc. has a 52 week low of $26.97 and a 52 week high of $37.19. The stock has a market cap of $16.23 billion, a P/E ratio of 18.87 and a beta of 0.75.

The firm also recently disclosed a semiannual dividend, which will be paid on Wednesday, November 1st. Investors of record on Friday, October 6th will be paid a dividend of $0.246 per share. This represents a yield of 1.37%. The ex-dividend date is Thursday, October 5th.

COPYRIGHT VIOLATION WARNING: “Marshall Wace North America L.P. Purchases Shares of 26,948 Smith & Nephew SNATS, Inc. (SNN)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/10/marshall-wace-north-america-l-p-purchases-shares-of-26948-smith-nephew-snats-inc-snn.html.

A number of research analysts have recently weighed in on the company. BidaskClub upgraded Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a report on Tuesday, August 1st. Zacks Investment Research upgraded Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Tuesday, July 11th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $38.00.

Smith & Nephew SNATS Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Stock Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related stocks with our FREE daily email newsletter.